title: Myeloablative radiolabeled antibody therapy with autologous bone marrow transplantation for relapsed B cell lymphomas.
authors.affiliation: University of Washington Medical Center, Seattle 98111, USA.
authors.forename: O W
authors.initials: OW
authors.lastname: Press
authors.forename: J F
authors.initials: JF
authors.lastname: Eary
authors.forename: F R
authors.initials: FR
authors.lastname: Appelbaum
authors.forename: I D
authors.initials: ID
authors.lastname: Bernstein
mesh_terms: D000906:Antibodies; D000911:Antibodies, Monoclonal; D016026:Bone Marrow Transplantation; D017321:Clinical Trials, Phase I as Topic; D017322:Clinical Trials, Phase II as Topic; D003131:Combined Modality Therapy; D006801:Humans; D007457:Iodine Radioisotopes / Q000627:therapeutic use; D016393:Lymphoma, B-Cell / Q000532:radiotherapy / Q000628:therapy*; D016499:Radioimmunotherapy / Q000009:adverse effects; D012008:Recurrence; D014182:Transplantation, Autologous
chemical_list: D000906:Antibodies; D000911:Antibodies, Monoclonal; D007457:Iodine Radioisotopes